Want to see HK:8158 full AI Analyst Report?
Earnings Data
Report Date
Apr 01, 2027TBA (Not Confirmed)
Period Ending
2026 (Q4)Consensus EPS Forecast
―Last Year’s EPS
0.08Same Quarter Last Year
Based on 0 Analysts Ratings
China Regenerative Medicine International Limited (HK:8158) Earnings, Revenues Date & History
HK:8158 Q2 2026 Earnings Report
HK:8158 Upcoming Earnings
China Regenerative Medicine International Limited's next earnings date is estimated for April 1, 2027, based on past reporting schedules.
HK:8158 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:8158 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 21, 2026 | HK$0.22 | HK$0.22 | 0.00% |
Mar 30, 2026 | HK$0.38 | HK$0.34 | -10.67% |
Nov 12, 2025 | HK$0.54 | HK$0.54 | 0.00% |
Aug 22, 2025 | HK$0.86 | HK$0.86 | 0.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does China Regenerative Medicine International Limited (HK:8158) report earnings?
China Regenerative Medicine International Limited (HK:8158) is schdueled to report earning on Apr 01, 2027, TBA (Not Confirmed).
What is China Regenerative Medicine International Limited (HK:8158) earnings time?
China Regenerative Medicine International Limited (HK:8158) earnings time is at Apr 01, 2027, TBA (Not Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of China Regenerative Medicine International Limited stock?
The P/E ratio of China Regenerative Medicine International Limited is N/A.
What is HK:8158 EPS forecast?
Currently, no data Available